JP2000510456A - 皮膚の状態処置用のオキサ二酸および関連化合物 - Google Patents
皮膚の状態処置用のオキサ二酸および関連化合物Info
- Publication number
- JP2000510456A JP2000510456A JP09538355A JP53835597A JP2000510456A JP 2000510456 A JP2000510456 A JP 2000510456A JP 09538355 A JP09538355 A JP 09538355A JP 53835597 A JP53835597 A JP 53835597A JP 2000510456 A JP2000510456 A JP 2000510456A
- Authority
- JP
- Japan
- Prior art keywords
- acid
- weight
- composition
- compound
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
- C07C69/708—Ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/362—Polycarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/68—Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/305—Saturated compounds containing more than one carboxyl group containing ether groups, groups, groups, or groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/24—Thermal properties
- A61K2800/244—Endothermic; Cooling; Cooling sensation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.適当な局所ビヒクルおよび式(I): 〔式中、R4は(CR5R6−CR7R8−X1)n−CR9R10−C(=X2)X3R11であ り、nは1乃至18の整数であり、R1、R2、R3、R5、R6、R7、R8、R9、 R10およびR11は独立して水素または非水素置換基であり、X、X1、X2、X3 、YおよびZは独立してO、NHまたはSである〕 の化合物からなる局所組成物。 2.式(I)の化合物が、該組成物の約0.1乃至約95重量%からなる請求 の範囲1記載の組成物。 3.式(I)の化合物が、該組成物の約1乃至約50重量%からなる請求の範 囲2記載の組成物。 4.式(I)の化合物が、該組成物の約5乃至約20重量%からなる請求の範 囲3記載の組成物。 5.nが2乃至12の整数である請求の範囲1記載の組成物。 6.更に、少なくとも2種の異なる式(I)の化合物の混合物からなる請求の 範囲1記載の組成物。 7.該化合物の非水素置換基が、アルキル、アルケニル、オキサアルキル、ア ラルキル、アリールからなる群から選ばれる請求の範囲1記載の組成物。 8.該非水素置換基が、メチル、エチル、プロピル、イソプロピル、ブチル、 イソブチル、ヘキシル、ヘプチル、オクチル、ノニル、ドデカニル、メトキシ、 エトキシ、プロポキシ、ブトキシ、シクロヘキセニル、ヒドロキシメチル、ヒド ロキシエチル、ヒドロキシプロピル、シクロブチルおよびシクロヘキサニルから なる群か選ばれる請求の範囲7記載の組成物。 9.R1、R2、R3、R5、R6、R7、R8、R9、R10およびR11が各々水素で ある請求の範囲1記載の組成物。 10.X、X1、X2、X3、YおよびZが各々酸素である請求の範囲1記載の 組成物。 11.X、X1、X2、X3、YおよびZが各々アミノ基である請求の範囲1記 載の組成物。 12.X、X1、X2、X3、YおよびZが各々硫黄である請求の範囲1記載の 組成物。 13.該化合物が、3,6−ジオキサオクタン二酸、3,6,9−トリオキサ ウンデカン二酸、3,6,9,12−テトラオキサテトラデカン二酸、3,6, 9,12,15−ペンタオキサヘプタデカン二酸、2−メチル−3,6,9−ト リオキサウンデカン二酸、2−エチル−3,6,9,12−テトラオキサテトラ デカン二酸、2−フェニル−3,6,9−トリオキサウンデカン二酸、3,6, 9−トリオキサウンデカン二酸ジエチルエステル、3,6,9−トリアミノウン デカン二酸、3,6,9,12−テトラアミノテトラデカン二酸、3−アミノ− 6,9−ジオキサウンデカン二酸、3,6−ジアミノ−9−オキサウンデカン二 酸、3,6,9−トリチオウンデカン二酸、3,6−ジチオ−9,12−ジオキ サテトラデカン二酸、3−アミノ−6,9−ジオキサウンデカン二酸モノアミド 、3−アミノ−6,9−ジオキサウンデカン二酸ジアミド、3,6,9−トリオ キサウンデカン二酸モノアミド、3,6,9−トリオキサウンデカン二酸ジアミ ド、2,10−ジメチル−3,6,9−トリオキサウンデカン二酸、2,10− ジメチル−3,9−ジチオ−6−オキサウンデカン二酸、およびそれらの混合物 からなる群から選ばれる請求の範囲1記載の組成物。 14.該ビヒクルがローション、クリームおよびゲルからなる群から選ばれる 請求の範囲1記載の組成物。 15.更に、抗かび剤、ビタミン、日焼け止め剤、レチノイド、抗アレルギー 剤、脱色素剤、抗炎症剤、麻酔薬、界面活性剤、モイスチャーライザー、剥離剤 、乳化剤、安定剤、防腐剤、殺菌剤、緩和剤、シックナー、潤滑剤、湿潤剤、キ レート化剤、フラグランス、着色剤、皮膚浸透増強剤からなる群から選ばれる少 なくとも1種の活性成分からなる請求の範囲1記載の組成物。 16.該組成物が7.0未満のpHを有する請求の範囲1記載の組成物。 17.該pHが約3.5乃至約7.0である請求の範囲16記載の組成物。 18.該pHが約3.5乃至約4.0である請求の範囲17記載の組成物。 19.該組成物が、式(I)の化合物約1乃至約50重量%からなり、7.0 未満のpHを有する請求の範囲2記載の組成物。 20.該局所ビヒクルが、式(I)の化合物0.1乃至約95重量%、緩和剤 0.5乃至約50重量%、乳化剤約0.1乃至約30重量%からなる請求の範囲 16記載の組成物。 21.該化合物が、3,6−ジオキサオクタン二酸、3,6,9−トリオキサ ウンデカン二酸、3,6,9,12−テトラオキサテトラデカン二酸および3, 6,9,12,15−ペンタオキサヘプタデカン二酸からなる群から選ばれ、該 緩和剤が、鉱油、ペトラタム、パラフィン、セレシン、オゾケライト、ミクロク リスタリンワックス、ペルヒドロスクアレン、ジメチルポリシロキサン、メチル フェニルポリシロキサン、シリコーン−グリコール共重合体、トリグリセリドエ ステル、アセチル化モノグリセリド、エトキシル化グリセリド、脂肪酸のアルキ ルエステル、脂肪酸およびアルコール、ラノリンおよびラノリン誘導体、多価ア ルコールエステル、ステロール、密蝋誘導体、多価アルコールおよびポリエーテ ル、および脂肪酸のアミドからなる群から選ばれ、該乳化剤がソルビタン、アル コキシル化脂肪アルコール、アルキルポリグリコシド、石鹸、硫酸アルキル、モ ノアルキルおよびジアルキルリン酸塩、スルホン酸アルキル、イソチアン酸アシ ルからなる群から選ばれる請求の範囲20記載の組成物。 22.該組成物が、水中油型乳濁液、油中水型乳濁液、水中油中水型乳濁液、 シリコーン液中水中油型乳濁液からなる群選ばれる形態である請求の範囲2記載 の組成物。 23.該局所ビヒクルが、水酸化アンモニウム、セテアリールアルコール/Ce teareth-20、EDTA、グリセリン、モノステアリン酸グリセリル、ヒドロキシ エチルセルロース、イミダゾリジリル尿素、メチルパラベン、ミリスチン酸ミリ スチル、パルミチン酸オクチルおよびプロピレングリコール、およびそれらの混 合物から選ばれる成分からなる請求の範囲14記載の組成物。 24.3,6,9−トリオキサウンデカン二酸約0.1乃至約20重量%およ びビヒクルからなる請求の範囲14記載の組成物。 25.該ビヒクルが、 (a)約2乃至約10重量%のグリセリン、 (b)約1乃至約10重量%のプロピレングリコール、 (c)約0.1乃至約2重量%のヒドロキシエチルセルロース、 (d)約0.1乃至約1重量%のイミダゾリジリル尿素、 (e)約0.01乃至約2重量%のEDTA二ナトリウムからなり、該組成物が 約7.0またはそれ以下のpHを有する請求の範囲22記載の組成物。 26.該ビヒクルが、 (a)約1乃至約10重量%のグリセリン、 (b)約1乃至約10重量%のプロピレングリコール、 (c)約1乃至約10重量%のパルミチン酸オクチル、 (d)約1乃至約10重量%のミリスチン酸ミリスチル、 (e)約1乃至約6重量%のセテアリールアルコール/Ceteareth-20、 (f)約0.5乃至約6重量%のモノステアリン酸グリセリル、 (g)約0.1乃至約2重量%のヒドロキシエチルセルロース、 (h)約0.1乃至約1重量%のイミダゾリジリル尿素、 約0.05乃至約0.5重量%のメチルパラベン、 (j)約0.01乃至約2重量%のEDTA二ナトリウムからなり、該組成物が 約7.0またはそれ以下のpHを有する請求の範囲24記載の組成物。 27.該ビヒクルが、 (a)約2乃至約10重量%のグリセリン、 (b)約1乃至約10重量%のパルミチン酸オクチル、 (c)約1乃至約10重量%のミリスチン酸ミリスチル、 (d)約1乃至約7重量%のセテアリールアルコール/Ceteareth-20、 (e)約1乃至約10重量%のプロピレングリコール、 (f)約1乃至約6重量%のモノステアリン酸グリセリル、 (g)約0.1乃至約2重量%のヒドロキシエチルセルロース、 (h)約0.1乃至約1重量%のイミダゾリジリル尿素、 (i)約0.05乃至約0.5重量%のメチルパラベン、 (j)約0.01乃至約2重量%のEDTA二ナトリウムからなり、該組成物が 約7.0またはそれ以下のpHを有する請求の範囲24記載の組成物。 28.式(I): 〔R4は(CR5R6−CR7R8−X1)n−CR9R10−C(=X2)X3R11であり、n は1乃至18の整数であり、R1、R2、R3、R5、R6、R7、R8、R9、R10お よびR11は独立して水素または非水素置換基であり、X、X1、X2、X3、Yお よびZは独立してO、NHまたはSである〕の化合物の有効量を皮膚に適用する ことからなる、異常な落屑により引き起こされた、それに伴うまたは悪化した皮 膚状態の処置方法。 29.該化合物を、局所組成物中で適当な局所ビヒクルと組み合わせる請求の 範囲28記載の方法。 30.更に、2種以上の異なる式(I)の化合物の混合物の有効量を、該皮膚 に適用することからなる請求の範囲28記載の方法。 31.式(I)の化合物が、該組成物の約0.1乃至約95重量%からなる請 求の範囲29記載の方法。 32.式(I)の化合物が、該組成物の約1乃至約50重量%からなる請求の 範囲31記載の方法。 33.nが2乃至12の整数である請求の範囲31記載の方法。 34.該化合物の非水素置換基が、アルキル、アルケニル、オキサアルキル、 アラルキル、アリールからなる群から選ばれる請求の範囲28記載の方法。 35.該化合物の非水素置換基が、メチル、エチル、プロピル、イソプロピル 、ブチル、イソブチル、ヘキシル、ヘプチル、オクチル、ノニル、ドデカニル、 メトキシ、エトキシ、プロポキシ、ブトキシ、シクロヘキセニル、ヒドロキシメ チル、ヒドロキシエチル、ヒドロキシプロピル、シクロブチルおよびシクロヘキ サニルからなる群から選ばれる請求の範囲34記載の方法。 36.R1、R2、R3、R5、R6、R7、R8、R9、R10およびR11が各々水素 である請求の範囲28記載の方法。 37.X、X1、X2、X3、YおよびZが各々酸素である請求の範囲28記載 の方法。 38.X、X1、X2、X3、YおよびZが各々アミノ基である請求の範囲28 記載の方法。 39.X、X1、X2、X3、YおよびZが各々硫黄である請求の範囲28記載 の方法。 40.該化合物が、3,6−ジオキサオクタン二酸、3,6,9−トリオキサ ウンデカン二酸、3,6,9,12−テトラオキサテトラデカン二酸、3,6, 9,12,15−ペンタオキサヘプタデカン二酸、2−メチル−3,6,9−ト リオキサウンデカン二酸、2−エチル−3,6,9,12−テトラオキサテトラ デカン二酸、2−フェニル−3,6,9−トリオキサウンデカン二酸、3,6, 9−トリオキサウンデカン二酸ジエチルエステル、3,6,9−トリアミノウン デカン二酸、3,6,9,12−テトラアミノテトラデカン二酸、3−アミノ− 6,9−ジオキサウンデカン二酸、3,6−ジアミノ−9−オキサウンデカン二 酸、3,6,9−トリチオウンデカン二酸、3,6−ジチオ−9,12−ジオキ サテトラデカン二酸、3−アミノ−6,9−ジオキサウンデカン二酸モノアミド 、3−アミノ−6,9−ジオキサウンデカン二酸ジアミド、3,6,9−トリオ キサウンデカン二酸モノアミド、3,6,9−トリオキサウンデカン二酸ジアミ ド、2,10−ジメチル−3,6,9−トリオキサウンデカン二酸、2,10− ジメチル−3,9−ジチオ−6−オキサウンデカン二酸、およびその混合物から なる群から選ばれる請求の範囲28記載の方法。 41.該化合物が3,6,9−トリオキサウンデカン酸である請求の範囲40 記載の方法。 42.該組成物が、更に抗かび剤、ビタミン、日焼け止め剤、レチノイド、抗 アレルギー剤、脱色素剤、抗炎症剤、麻酔剤、界面活性剤、モイスチャーライザ ー、剥離剤、乳化剤、安定剤、防腐剤、防腐薬、緩和剤、シックナー、潤滑剤、 湿潤剤、キレート化剤、フラグランス、着色剤、皮膚浸透増強剤からなる群から 選ばれる少なくとも1種の活性成分からなる請求の範囲29記載の方法。 43.該皮膚状態が、乾燥皮膚、魚鱗癬、手掌および足底の角化症、ふけ、慢 性単純苔癬、ダリエルス病、角化症、ほくろ、老齢斑点、黒皮症、斑点皮膚、ア クネ、乾癬、湿疹、かゆみ、炎症性皮膚病、萎縮線条、いぼ、べんち、皮膚科学 的老化の徴候、皮膚のしわ、口領域の周りの細かいしわ、不規則色素沈着、黄ば み、皮膚の弾力と弾性の喪失、爪、表皮、髪に関連する障害からなる群から選ば れる請求の範囲28記載の方法。 44.式(I): 〔式中、R4は(CR5R6−CR7R8−X1)n−CR9R10−C(=X2)X3R11であ り、nは1乃至18の整数であり、R1、R2、R3、R5、R6、R7、R8、R9、 R10およびR11は独立して水素または非水素置換基であり、X、X1、X2、X3 、YおよびZは独立してO、NHまたはSである〕の化合物を皮膚に適用するこ とからなる皮膚剥脱方法。 45.式(I):〔式中、R4は(CR5R6−CR7R8−X1)n−CR9R10−C(=X2)X3R11であ り、nは1乃至18の整数であり、R1、R2、R3、R5、R6、R7、R8、R9、 R10およびR11は独立して水素または非水素置換基であり、X、X1、X2、X3 、YおよびZは独立してO、NHまたはSである〕の化合物を髪に適用すること からなる髪の柔軟化方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/636,540 US5834513A (en) | 1996-04-25 | 1996-04-25 | Oxa diacids and related compounds for treating skin conditions |
US08/636,540 | 1996-04-25 | ||
PCT/US1997/006973 WO1997039726A1 (en) | 1996-04-25 | 1997-04-25 | Oxa diacids and related compounds for treating skin conditions |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2000510456A true JP2000510456A (ja) | 2000-08-15 |
JP3779733B2 JP3779733B2 (ja) | 2006-05-31 |
Family
ID=24552353
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP53835597A Expired - Fee Related JP3779733B2 (ja) | 1996-04-25 | 1997-04-25 | 皮膚の状態処置用のオキサ二酸および関連化合物 |
Country Status (10)
Country | Link |
---|---|
US (1) | US5834513A (ja) |
EP (1) | EP0910331B1 (ja) |
JP (1) | JP3779733B2 (ja) |
CN (1) | CN1139375C (ja) |
AR (1) | AR006867A1 (ja) |
AT (1) | ATE275383T1 (ja) |
BR (1) | BR9708747A (ja) |
CA (1) | CA2251746C (ja) |
DE (1) | DE69730604T2 (ja) |
WO (1) | WO1997039726A1 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003501505A (ja) * | 1999-05-28 | 2003-01-14 | ニュートロジーナ・コーポレイション | サリチル酸を含有しているシリコーン・ゲル |
JP2009046510A (ja) * | 2003-05-12 | 2009-03-05 | Avon Products Inc | 皮膚の審美的外観を改善する化粧品組成物及びそれを使用する方法 |
Families Citing this family (82)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5932229A (en) * | 1996-04-25 | 1999-08-03 | Avon Products, Inc. | Oxa diacids and related compounds for treating skin conditions |
GB9610122D0 (en) * | 1996-05-15 | 1996-07-24 | Reckitt & Colmann Prod Ltd | Organic compositions |
US5847003A (en) * | 1996-06-04 | 1998-12-08 | Avon Products, Inc. | Oxa acids and related compounds for treating skin conditions |
FR2761601A1 (fr) * | 1997-04-04 | 1998-10-09 | Oreal | Compositions cosmetiques autobronzantes |
US8039026B1 (en) | 1997-07-28 | 2011-10-18 | Johnson & Johnson Consumer Companies, Inc | Methods for treating skin pigmentation |
US6383495B1 (en) * | 1997-12-08 | 2002-05-07 | Council Of Scientific & Industrial Research | Herbal formulation useful for treatment of skin disorders |
AU756515B2 (en) * | 1998-03-13 | 2003-01-16 | Johns Hopkins University School Of Medicine, The | The use of a protein tyrosine inhibitor such as genistein in the treatment of diabetic retinopathy or ocular inflammation |
JP2002506807A (ja) * | 1998-03-16 | 2002-03-05 | ザ、プロクター、エンド、ギャンブル、カンパニー | 皮膚外観を調節する方法 |
WO1999055352A1 (en) * | 1998-04-29 | 1999-11-04 | Avon Products, Inc. | Skin whitening composition |
US8093293B2 (en) | 1998-07-06 | 2012-01-10 | Johnson & Johnson Consumer Companies, Inc. | Methods for treating skin conditions |
US8106094B2 (en) | 1998-07-06 | 2012-01-31 | Johnson & Johnson Consumer Companies, Inc. | Compositions and methods for treating skin conditions |
US6136339A (en) | 1998-08-21 | 2000-10-24 | Gardiner; Paul T. | Food supplements and methods comprising lipoic acid and creatine |
FR2782922B1 (fr) * | 1998-09-09 | 2002-07-19 | Oreal | Composition contenant de l'uree et ses utilisations dans le domaine cosmetique et/ou dermatologique |
US20040131579A1 (en) * | 1998-09-10 | 2004-07-08 | Avon Products, Inc. | Method and compositions for reducing dermatological aging and for reducing bruising |
AU6034599A (en) * | 1998-09-10 | 2000-03-27 | Avon Products Inc. | Method and compositions for reducing dermatological aging and for reducing bruising |
US6521237B2 (en) * | 1998-11-12 | 2003-02-18 | Johnson & Johnson Consumer Companies, Inc. | Skin care composition |
WO2000057876A1 (en) * | 1999-03-26 | 2000-10-05 | Lipogenics, Inc. | Novel antioxidant formulations and methods for using them |
EP1055408A1 (de) * | 1999-05-26 | 2000-11-29 | Nutrinova Nutrition Specialties & Food Ingredients GmbH | Sorbatkonservierte Mittel, Verfahren zu deren Herstellung und ihre Verwendung |
US6242491B1 (en) * | 1999-06-25 | 2001-06-05 | Rima Kaddurah-Daouk | Use of creatine or creatine compounds for skin preservation |
US6989163B2 (en) * | 2001-10-23 | 2006-01-24 | 40 J's Llc | Arrangement to enhance a woman's sexual sensitivity by a combination of phytoestrogens, L-arginine and menthol |
US7985404B1 (en) | 1999-07-27 | 2011-07-26 | Johnson & Johnson Consumer Companies, Inc. | Reducing hair growth, hair follicle and hair shaft size and hair pigmentation |
US6309662B1 (en) * | 1999-09-23 | 2001-10-30 | Janet Buchanan | Use of anti-inflammatory drugs for treatment of dermatological conditions |
US6358517B1 (en) | 1999-10-22 | 2002-03-19 | Unilever Home & Personal Care Usa, Division Of Conopco | Cosmetic compositions containing resveratrol and retinoids |
US6277362B1 (en) | 1999-10-26 | 2001-08-21 | Isw, Inc. | After shave treatment preparation |
US7309688B2 (en) * | 2000-10-27 | 2007-12-18 | Johnson & Johnson Consumer Companies | Topical anti-cancer compositions and methods of use thereof |
US6582724B2 (en) * | 1999-12-16 | 2003-06-24 | Dermatrends, Inc. | Dual enhancer composition for topical and transdermal drug delivery |
US6586000B2 (en) * | 1999-12-16 | 2003-07-01 | Dermatrends, Inc. | Hydroxide-releasing agents as skin permeation enhancers |
US6558695B2 (en) | 1999-12-16 | 2003-05-06 | Dermatrends, Inc. | Topical and transdermal administration of peptidyl drugs using hydroxide releasing agents as permeation enhancers |
US20030104041A1 (en) * | 1999-12-16 | 2003-06-05 | Tsung-Min Hsu | Transdermal and topical administration of drugs using basic permeation enhancers |
US6645520B2 (en) | 1999-12-16 | 2003-11-11 | Dermatrends, Inc. | Transdermal administration of nonsteroidal anti-inflammatory drugs using hydroxide-releasing agents as permeation enhancers |
US6562370B2 (en) * | 1999-12-16 | 2003-05-13 | Dermatrends, Inc. | Transdermal administration of steroid drugs using hydroxide-releasing agents as permeation enhancers |
US6562368B2 (en) | 1999-12-16 | 2003-05-13 | Dermatrends, Inc. | Transdermal administration of oxybutynin using hydroxide-releasing agents as permeation enhancers |
US6562369B2 (en) * | 1999-12-16 | 2003-05-13 | Dermatrends, Inc. | Transdermal administration of androgenic drugs hydroxide-releasing agents as permeation enhancers |
US6565879B1 (en) | 1999-12-16 | 2003-05-20 | Dermatrends, Inc. | Topical and transdermal administration of peptidyl drugs with hydroxide-releasing agents as skin permeation enhancers |
US6673363B2 (en) | 1999-12-16 | 2004-01-06 | Dermatrends, Inc. | Transdermal and topical administration of local anesthetic agents using basic enhancers |
DE19961934A1 (de) * | 1999-12-22 | 2001-06-28 | Henkel Kgaa | Blondiermittel |
FI111686B (fi) * | 2000-04-20 | 2003-09-15 | Simo Rasi | Kosmeettinen tai ihonhoidollinen voidekoostumus, sen valmistusmenetelmä ja käyttö |
DE10032964B4 (de) * | 2000-07-06 | 2017-10-12 | Beiersdorf Ag | Verwendung von Kreatin in kosmetischen oder dermatologischen Zubereitungen |
US8431550B2 (en) | 2000-10-27 | 2013-04-30 | Johnson & Johnson Consumer Companies, Inc. | Topical anti-cancer compositions and methods of use thereof |
US6583184B1 (en) * | 2000-11-27 | 2003-06-24 | Avon Products, Inc. | Compositions having comfrey and methods for reducing retinoid-induced skin irritation |
US6565864B2 (en) * | 2000-12-28 | 2003-05-20 | Unilever Home & Personal Care Usa, A Division Of Conopco, Inc. | Skin care product containing retinoids and phytoestrogens in a dual compartment package |
US7192615B2 (en) | 2001-02-28 | 2007-03-20 | J&J Consumer Companies, Inc. | Compositions containing legume products |
US7820688B2 (en) * | 2001-04-27 | 2010-10-26 | Memorial Sloan-Kettering Cancer Center | Topical anesthetic/opioid formulations and uses thereof |
DE10126501A1 (de) * | 2001-05-30 | 2002-12-12 | Aventis Pharma Gmbh | Zubereitung zur Entfernung von abnormen Keratinmaterial |
DE10129502A1 (de) * | 2001-06-19 | 2003-01-09 | Beiersdorf Ag | Verwendung von Carnitin und/oder einem oder mehreren Acyl-Carnitinen zur Herstellung von kosmetischen oder dermatologischen Zubereitungen zur Steigerung der Ceramidbiosynthese |
DE10129504A1 (de) * | 2001-06-19 | 2003-01-09 | Beiersdorf Ag | Verwendung von Carnitin und/oder einem oder mehreren Acyl-Carnitinen zur Herstellung von kosmetischen oder dermatologischen Zubereitungen zur Behandlung und/oder Prophylaxe von Pigmentierungsstörungen |
DE10133198A1 (de) * | 2001-07-07 | 2003-01-23 | Beiersdorf Ag | Kreatin enthaltende kosmetische und dermatologische Zubereitungen zur Behandlung und aktiven Prävention trockener Haut und anderer negativer Veränderungen der physiologischen Homöostase der gesunden Haut |
DE10133200A1 (de) * | 2001-07-07 | 2003-01-23 | Beiersdorf Ag | Carnitin enthaltende kosmetische und dermatologische Zubereitungen zur Behandlung und aktiven Prävention trockener Haut und anderer negativer Veränderungen der physiologischen Homöostase der gesunden Haut |
US6641824B2 (en) * | 2001-11-09 | 2003-11-04 | Avon Products, Inc. | Skin treatment using a new retinoid |
US6866856B2 (en) * | 2002-12-31 | 2005-03-15 | Avon Products, Inc. | Compositions and delivery methods for the treatment of wrinkles, fine lines and hyperhidrosis |
US7060303B2 (en) * | 2002-12-31 | 2006-06-13 | Avon Products, Inc. | Use of purslane to treat facial wrinkles |
EP1444970B1 (en) * | 2003-02-05 | 2011-08-17 | Kao Corporation | Absorbent article |
EP1444969B1 (en) * | 2003-02-05 | 2011-08-31 | Kao Corporation | Absorbent article |
KR20060125746A (ko) * | 2003-10-29 | 2006-12-06 | 죤슨 앤 죤슨 컨슈머 프랑스 에스에이에스 | 대두 제품과 이산을 포함한 조성물 |
DE10355716A1 (de) * | 2003-11-26 | 2005-06-23 | Beiersdorf Ag | Kosmetische Zubereitungen mit einem Gehalt Kreatin und/oder Kreatinderivaten und/oder Kreatinin und/oderKreatininderivaten und organischen Verdickern |
DE10355715A1 (de) * | 2003-11-26 | 2005-06-16 | Beiersdorf Ag | Wirkstoffkombinationen Kreatin und/oder Kreatinderivaten und/oder Kreatinin und/oder Kreatininderivaten und einer wirksamen Menge an Retinoiden, insbesondere Retinol bzw. Retinylpalmitat und Zubereitungen, solche Wirkstoffkombinationen enthaltend |
DE10355714A1 (de) * | 2003-11-26 | 2005-06-30 | Beiersdorf Ag | Wirkstoffkombination aus Kreatin und/oder Kreatinin, Phenoxyethanol und gewünschtenfalls Glycerin |
US7504385B2 (en) * | 2003-12-17 | 2009-03-17 | Avon Products, Inc. | si-RNA-mediated gene silencing technology to inhibit tyrosinase and reduce pigmentation |
US20050136015A1 (en) * | 2003-12-17 | 2005-06-23 | McKie Derrick B. | Topical use of halosalicylic acid derivatives |
DE102004060314A1 (de) * | 2004-12-08 | 2006-08-31 | Beiersdorf Ag | Wirkstoffkombinationen aus einem oder mehreren Isoflavonoiden und Carnitin und/oder einem oder mehreren Acyl-Carnitinen |
US8221766B2 (en) * | 2004-12-22 | 2012-07-17 | Avon Products, Inc. | Use of plant extracts to prevent and/or reduce the signs of subjective discomfort and/or irritation in the topical application of cosmetic products |
US7351745B2 (en) | 2004-12-22 | 2008-04-01 | Avon Products, Inc | Compositions and methods of their use for improving the condition and appearance of skin |
US7618662B2 (en) * | 2004-12-22 | 2009-11-17 | Avon Products, Inc | Use of natural plant extracts in cosmetic compositions |
US7514092B2 (en) | 2004-12-22 | 2009-04-07 | Avon Products, Inc. | Compositions and methods of their use for improving the condition and appearance of skin |
US7410658B2 (en) * | 2004-12-22 | 2008-08-12 | Avon Products, Inc. | Use of Alisma orientale in cosmetics and compositions thereof |
EP1951260A4 (en) | 2005-10-21 | 2009-11-11 | Bezwada Biomedical Llc | FUNCTIONALIZED PHENOLIC COMPOUNDS AND POURABLE ARTICLES THEREOF |
DE102005056538A1 (de) * | 2005-11-28 | 2007-05-31 | Merz Pharma Gmbh & Co. Kgaa | Zusammensetzungen, enthaltend Proteine zum Transfer / Recycling strukturell veränderter Lipide aus Biomembranen, sowie deren Anwendungen |
US20080220026A1 (en) * | 2007-03-06 | 2008-09-11 | Prithwiraj Maitra | Mesoporous material compositions and methods of their use for improving the appearance of biological surfaces |
US7642062B2 (en) * | 2006-12-29 | 2010-01-05 | Avon Products Inc. | Compositions and methods of their use for improving the condition and appearance of skin |
US8217134B2 (en) | 2007-08-30 | 2012-07-10 | Bezwada Biomedical, Llc | Controlled release of biologically active compounds |
US8026285B2 (en) | 2007-09-04 | 2011-09-27 | Bezwada Biomedical, Llc | Control release of biologically active compounds from multi-armed oligomers |
US8048980B2 (en) | 2007-09-17 | 2011-11-01 | Bezwada Biomedical, Llc | Hydrolysable linkers and cross-linkers for absorbable polymers |
US8053591B2 (en) * | 2007-09-26 | 2011-11-08 | Bezwada Biomedical, Llc | Functionalized biodegradable triclosan monomers and oligomers for controlled release |
US8367747B2 (en) | 2008-05-23 | 2013-02-05 | Bezwada Biomedical, Llc | Bioabsorbable polymers from bioabsorbable polyisocyanates and uses thereof |
EP2588062B1 (en) | 2010-06-30 | 2019-05-29 | Avon Products, Inc. | Use of tiliacora triandra in cosmetics and compositions thereof |
CN104207991B (zh) | 2010-06-30 | 2017-04-12 | 雅芳产品公司 | 用于刺激magp‑1以改善皮肤外观的组合物和方法 |
US9259343B2 (en) | 2012-07-06 | 2016-02-16 | Newman Technologies LLC | Device for mitigating plantar fasciitis |
US9861645B2 (en) | 2012-12-28 | 2018-01-09 | Rak Holdings Llc | Anti-itch scalp treatment compositions and combinations |
BR112018008556A2 (pt) | 2015-10-30 | 2018-10-23 | Patagonia Pharmaceuticals Llc | ?composições farmacêuticas e métodos para tratar ictiose congênita? |
CN105816344B (zh) * | 2015-12-28 | 2018-08-17 | 天津伊瑞雅生物科技有限公司 | 一种含有吡咯并喹啉醌和n-乙酰基神经氨酸的组合物 |
BE1025004B1 (nl) | 2017-02-24 | 2018-09-24 | Oystershell Nv | Afpelbare nagellak |
NL2035417A (en) | 2022-07-19 | 2024-01-26 | Coty Inc | Cosmetic composition |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2404047A1 (de) * | 1974-01-29 | 1975-08-14 | Henkel & Cie Gmbh | Hautpflege- und hautschutzmittel mit einem gehalt an haut-feuchthaltemitteln |
DE2714564C2 (de) * | 1977-04-01 | 1986-01-02 | Chemische Werke Hüls AG, 4370 Marl | Verfahren zur Herstellung von cyclischen Diestern der Undecandisäure |
US4386104A (en) * | 1977-04-19 | 1983-05-31 | Nazzaro Porro Marcella | Process for the treatment of acne |
IT1114950B (it) * | 1977-12-30 | 1986-02-03 | Porro Marcella | Composizioni per il trattamento e la terapia di acne |
DE2936123A1 (de) * | 1979-09-07 | 1981-04-02 | Hoechst Ag, 6000 Frankfurt | Verfahren zur herstellung von alkoxyessigsaeuren |
US4721579A (en) * | 1980-08-15 | 1988-01-26 | Basf Corporation | Sodium carboxymethyl derivatives of polyoxyalkylene glycols, their production, and use in functional fluids |
US4721479A (en) * | 1984-11-19 | 1988-01-26 | Curtis Shuman | Safety jumper cables |
JPS62149797A (ja) * | 1985-12-24 | 1987-07-03 | 花王株式会社 | 洗浄剤組成物 |
DE3640708C2 (de) * | 1986-11-28 | 1995-05-18 | Schering Ag | Verbesserte metallhaltige Pharmazeutika |
US5091171B2 (en) * | 1986-12-23 | 1997-07-15 | Tristrata Inc | Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use |
US4885282A (en) * | 1987-07-02 | 1989-12-05 | Thornfeldt Carl R | Treatment of hyperhidrosis, ichthyosis and wrinkling |
DE3811081A1 (de) * | 1988-03-30 | 1989-10-12 | Schering Ag | Verwendung von topisch applizierbaren praeparaten zur behandlung der altershaut |
US4916206A (en) * | 1988-11-14 | 1990-04-10 | Olin Corporation | Nitramine-containing homopolymers and co-polymers and a process for the preparation thereof |
US5008443A (en) * | 1988-11-14 | 1991-04-16 | Olin Corporation | Process for the preparation of nitramine-containing homopolymers and co-polymers |
DE3901279A1 (de) * | 1989-01-18 | 1990-07-19 | Hoechst Ag | Verwendung von polyamidoaminen als haerter fuer epoxidharze und diese enthaltende haertbare mischungen |
US5087440A (en) * | 1989-07-31 | 1992-02-11 | Salutar, Inc. | Heterocyclic derivatives of DTPA used for magnetic resonance imaging |
JP2876137B2 (ja) * | 1989-11-29 | 1999-03-31 | 川研ファインケミカル株式会社 | 毛髪化粧料組成物 |
GB9003201D0 (en) * | 1990-02-13 | 1990-04-11 | Unilever Plc | Cosmetic composition |
DE4206392A1 (de) * | 1992-02-29 | 1993-09-02 | Hoechst Ag | Haertungsmittel fuer epoxidharze |
JPH07304653A (ja) * | 1994-05-16 | 1995-11-21 | Shiseido Co Ltd | 洗浄剤組成物 |
US5464929A (en) * | 1995-03-06 | 1995-11-07 | Ethicon, Inc. | Absorbable polyoxaesters |
-
1996
- 1996-04-25 US US08/636,540 patent/US5834513A/en not_active Expired - Lifetime
-
1997
- 1997-04-25 AR ARP970101721A patent/AR006867A1/es active IP Right Grant
- 1997-04-25 DE DE69730604T patent/DE69730604T2/de not_active Expired - Lifetime
- 1997-04-25 EP EP97924518A patent/EP0910331B1/en not_active Expired - Lifetime
- 1997-04-25 CN CNB971940320A patent/CN1139375C/zh not_active Expired - Lifetime
- 1997-04-25 CA CA2251746A patent/CA2251746C/en not_active Expired - Lifetime
- 1997-04-25 JP JP53835597A patent/JP3779733B2/ja not_active Expired - Fee Related
- 1997-04-25 WO PCT/US1997/006973 patent/WO1997039726A1/en active IP Right Grant
- 1997-04-25 AT AT97924518T patent/ATE275383T1/de not_active IP Right Cessation
- 1997-04-25 BR BR9708747-5A patent/BR9708747A/pt not_active IP Right Cessation
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003501505A (ja) * | 1999-05-28 | 2003-01-14 | ニュートロジーナ・コーポレイション | サリチル酸を含有しているシリコーン・ゲル |
JP2009046510A (ja) * | 2003-05-12 | 2009-03-05 | Avon Products Inc | 皮膚の審美的外観を改善する化粧品組成物及びそれを使用する方法 |
Also Published As
Publication number | Publication date |
---|---|
CA2251746A1 (en) | 1997-10-30 |
BR9708747A (pt) | 2000-01-04 |
AR006867A1 (es) | 1999-09-29 |
EP0910331A1 (en) | 1999-04-28 |
CN1216460A (zh) | 1999-05-12 |
CN1139375C (zh) | 2004-02-25 |
EP0910331B1 (en) | 2004-09-08 |
WO1997039726A1 (en) | 1997-10-30 |
DE69730604D1 (de) | 2004-10-14 |
ATE275383T1 (de) | 2004-09-15 |
DE69730604T2 (de) | 2005-09-29 |
US5834513A (en) | 1998-11-10 |
CA2251746C (en) | 2011-04-19 |
EP0910331A4 (en) | 1999-11-03 |
JP3779733B2 (ja) | 2006-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3779733B2 (ja) | 皮膚の状態処置用のオキサ二酸および関連化合物 | |
US6333356B1 (en) | Compounds for treating skin conditions | |
US5932229A (en) | Oxa diacids and related compounds for treating skin conditions | |
JP3610983B2 (ja) | アスコルビル−ホスホリル−コレステロール | |
ES2702607T3 (es) | Composición cosmética y método de retardo del crecimiento del vello | |
KR101687042B1 (ko) | 칼슘 봉쇄 조성물 및 피부 색소침착 장애 및 병증의 치료 방법 | |
WO2006117885A1 (ja) | 皮膚外用剤 | |
FR2854897A1 (fr) | Compositions cosmetiques ou dermopharmaceutiques pour reduire les signes du vieillissement cutane. | |
US5922335A (en) | Uses for ascorbyl-phosphoryl-cholesterol in topical compositions | |
CA2798121C (en) | Topical composition and use thereof for the prophylaxis and the treatment of defects connected to inflammatory dermopathies | |
EP1080719A2 (en) | Methods for potentiation of efficacy of topical actives by mono-acyl-(lyso)-glycerophosholipids | |
JPH10212231A (ja) | 皮膚の状態を手入れするためのオキサ・ジアシッドと関連化合物 | |
AU740577B2 (en) | Ascorbyl-phosphoryl-cholesterol | |
MXPA98010267A (en) | Oxa acids and derivative compounds for the treatment of transtornes of the p | |
JP2007277134A (ja) | インターロイキン−6産生抑制剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20040426 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20050111 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20050411 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20050530 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20050711 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20050906 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20051206 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20060207 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20060303 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090310 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100310 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100310 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110310 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120310 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120310 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130310 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130310 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140310 Year of fee payment: 8 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |